Key points are not available for this paper at this time.
The efficacy of conventional treatments for previously treated advanced BTC patients is poor and could be improved by novel therapies.
Amonkar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: